Neurology · 1996 · 89 citations · 16 references
MedicineNeurologyDementiaMovement DisordersNeuropathologyCreutzfeldt-jakob DiseaseMotor Neuron DiseasesDiagnosis Of Creutzfeldt-jakob DiseaseDisease DurationEarly Neurologic DeteriorationGrowth Hormone FamilyIatrogenic Creutzfeldt-jakob DiseaseNeurologic Deterioration DetectionOcular Motor Abnormalities
We diagnosed Cruetzfeldt-Jakob disease in 34 patients (16 definite, 18 probable) who had received human growth hormone extract for various period of time (mean +/- SD, 2.9 years), but particularly during the period between January 1984 and July 1985, a potential high-risk factor. Disease duration for deceased patients (n = 30) was 17 +/- 9 months. The clinical picture was homogeneous, starting with cerebellar ataxia and ocular motor disorders in about 90% of the patients. Neurologic deterioration, including dementia and myoclonic jerks, occurred within months. The high number of cases (1.5% of those treated between 1959 and 1988, 3% of those treated during the putative high-risk period) is still unexplained. We discuss the possibility that new cases will be detected,the risk of contaminating the general public, and the sanitary measures undertaken to prevent this.
16
Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the Chimpanzee
Clarence J. Gibbs, D. Carleton Gajdusek, David M. Asher et al. · Science · 1968 · 778 citations
Medicine, Neurology, Neuroscience +13
Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene
Rudolph A. Riemersma, David A. Wood, M. F. Oliver et al. · The Lancet · 1991 · 775 citations
Neurochemical Studies of Early-Onset Alzheimer's Disease
Paul T. Francis, Alan M. Palmer, Neil R. Sims et al. · New England Journal of Medicine · 1985 · 358 citations
L. Monari, Shu G. Chen, Patrick O. Brown et al. · Proceedings of the National Academy of Sciences · 1994 · 332 citations · Full text